WV
Insider
Weegen Felice Isabel Verduyn-van
DirectorWeegen Felice Isabel Verduyn-van (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Evommune, Inc. (EVMN). Across 1 priced purchase filing, the average 21-session return was -11.5% from execution and +0.7% from disclosure (delay-adjusted; derived). The largest single filing was $25.0M of EVMN (1,562,500 sh × $16.00, as filed), executed Nov 7 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-11.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+0.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
5d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$25.0M
shares × price, as filed
Last traded
Nov 7 2025
Filed Nov 12 2025
Median ADV $8.9M across their filed names
Open performance→Volume by month
Buys $25.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EVMNRecent filings
EVMNPURCHASE
Evommune, Inc.
View filing →
$25.0M1,562,500 sh × $16.00
Exec Nov 7 2025
Filed Nov 12 2025 · 4:24 PM ET